It’s a momentous week in Georgia, Washington and these United States. In this special episode of the HealthBiz podcast, Bloomberg Intelligence Analyst, Brian Rye and I discuss the health policy implications of the likely 50+1 Democratic Senate majority. Listen in as we discuss drug pricing, Medicare Advantage, and the public option.
The HealthBiz podcast is available on Spotify, Apple Podcasts, Google Podcasts and many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.
Check out the rough (AI generated) transcript.